Approval · Notice of Compliance 20242 · 2017
FOQUEST: Notice of Compliance 20242
Issued December 6, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20242
- Date
- December 6, 2017
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- METHYLPHENIDATE HYDROCHLORIDE 25 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 35 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 45 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 55 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 70 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 85 MG per CAP
- METHYLPHENIDATE HYDROCHLORIDE 100 MG per CAP